5 Best Stocks Under $11 in Cathie Wood’s Portfolio

3. Enlivex Therapeutics Ltd. (NASDAQ:ENLV)

ARK Investment Management Stake Value: $4,582,000
Percentage of ARK Investment Management’s 13F Portfolio: 0.01%
Number of Hedge Fund Holders: 2
Price per Share as of Nov. 5, 2021: $8.72

Enlivex Therapeutics Ltd. (NASDAQ:ENLV), a clinical-stage immunotherapy startup, has obtained notice of authorization from the Israeli Patent Office for a new patent application covering the company’s immunotherapy product candidate Allocetra.

In the second quarter, Cathie Wood’s ARK Investment Management raised its position in Enlivex Therapeutics Ltd. by 9% to 514,807 shares, accounting for just over 0.01% of the overall portfolio. At the end of the second quarter of 2021, 2 hedge funds in the database of Insider Monkey held stakes worth $6.32 million in Enlivex Therapeutics Ltd. (NASDAQ:ENLV), the same as in the preceding quarter worth $8.50 million.